Literature DB >> 31679210

Familial Pancreatic Cancer: A Critical Review.

Asad Ur Rahman1, Effa Zahid2, Muhammad Talha Khan3, Awais Naeem4, Saeed Ali5, Mamoon Ur Rashid6, Sarfraz Ahmad7.   

Abstract

Up to 20% of patients with pancreatic cancer have a family history of the disease. Familial pancreatic cancer is defined as at least two first-degree relatives with pancreatic cancer that occurs without being part of a cancer syndrome. Although this does not follow a specific Mendelian pattern of inheritance, research is underway to better understand this cohort of patients. Recent expert opinion/recommendations encourage physicians treating patients with pancreatic cancer to ask them to consider having germline testing. Herein, we summarize the current peer-reviewed literature on the most common syndromes associated with pancreatic cancer, associated genetic mutations, and recommendations from various consortia regarding screening strategies. Lastly, we describe the economic impact of pancreatic cancer and the impact of screening tools in high-risk populations.

Entities:  

Mesh:

Year:  2019        PMID: 31679210     DOI: 10.1615/CritRevOncog.2019031637

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  2 in total

Review 1.  Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.

Authors:  Silviu Stanciu; Florentina Ionita-Radu; Constantin Stefani; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Alexandra Ripszky Totan; Mariana Jinga
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

2.  CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer.

Authors:  Zixuan Zhou; Zuyi Ma; Zhenchong Li; Hongkai Zhuang; Chunsheng Liu; Yuanfeng Gong; Shanzhou Huang; Chuanzhao Zhang; Baohua Hou
Journal:  J Cancer       Date:  2021-08-03       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.